Letteratura scientifica selezionata sul tema "Télésurveillance des dispositifs médicaux"
Cita una fonte nei formati APA, MLA, Chicago, Harvard e in molti altri stili
Consulta la lista di attuali articoli, libri, tesi, atti di convegni e altre fonti scientifiche attinenti al tema "Télésurveillance des dispositifs médicaux".
Accanto a ogni fonte nell'elenco di riferimenti c'è un pulsante "Aggiungi alla bibliografia". Premilo e genereremo automaticamente la citazione bibliografica dell'opera scelta nello stile citazionale di cui hai bisogno: APA, MLA, Harvard, Chicago, Vancouver ecc.
Puoi anche scaricare il testo completo della pubblicazione scientifica nel formato .pdf e leggere online l'abstract (il sommario) dell'opera se è presente nei metadati.
Articoli di riviste sul tema "Télésurveillance des dispositifs médicaux"
Desire, Amélie, e Charlotte Gourio. "Dispositifs médicaux". Actualités Pharmaceutiques Hospitalières 3, n. 12 (dicembre 2007): 42–48. http://dx.doi.org/10.1016/s1769-7344(07)70019-7.
Testo completoRuault, Céline, e Charlotte Gourio. "Dispositifs médicaux". Actualités Pharmaceutiques Hospitalières 5, n. 17 (febbraio 2009): 38. http://dx.doi.org/10.1016/s1769-7344(09)70135-0.
Testo completoCerbelaud, Nadège, e Charlotte Gourio. "Dispositifs médicaux". Actualités Pharmaceutiques Hospitalières 5, n. 17 (febbraio 2009): 39–40. http://dx.doi.org/10.1016/s1769-7344(09)70136-2.
Testo completoBrischoux, Sonia. "Dispositifs médicaux". Actualités Pharmaceutiques Hospitalières 5, n. 17 (febbraio 2009): 41–42. http://dx.doi.org/10.1016/s1769-7344(09)70137-4.
Testo completoCrickx, B., e X. Arrault. "Dispositifs médicaux implantables". Annales de Dermatologie et de Vénéréologie 135, n. 1 (gennaio 2008): 66–69. http://dx.doi.org/10.1016/s0151-9638(08)70214-x.
Testo completoLetard, J. C. "Les dispositifs médicaux". Acta Endoscopica 33, n. 2 (aprile 2003): 269–71. http://dx.doi.org/10.1007/bf03028419.
Testo completoHajjar, Joseph. "Traitement des dispositifs médicaux". Le Praticien en Anesthésie Réanimation 9, n. 6 (dicembre 2005): 482–87. http://dx.doi.org/10.1016/s1279-7960(05)83775-1.
Testo completoTétart, Florence. "Dispositifs médicaux et allergies". Dermato Mag 11, n. 3 (1 giugno 2023): 181–83. http://dx.doi.org/10.1684/dmg.2023.644.
Testo completoSommer, Johanna, e Martine Bideau. "Dispositifs médicaux moins polluants". Revue Médicale Suisse 20, n. 877 (2024): 1125. http://dx.doi.org/10.53738/revmed.2024.20.877.1125.
Testo completoAncellin, Joël. "La sécurité des dispositifs médicaux". RBM-News 17, n. 4 (gennaio 1995): M5. http://dx.doi.org/10.1016/s0222-0776(00)88939-7.
Testo completoTesi sul tema "Télésurveillance des dispositifs médicaux"
Chehbani, Amel. "Etude et mise en œuvre d’un système communicant sans fil et sans radio pour la mesure de paramètres physiologiques des nouveau-nés". Electronic Thesis or Diss., Limoges, 2024. http://www.theses.fr/2024LIMO0009.
Testo completoThe weak immune systems in the elderly, newborns and preterm infants increase their susceptibility to cardiovascular disease and heart failure. Indeed, symptoms of cardiac pathology can be quite unusual and sporadic in this population. This requires continuous monitoring of cardiac activity by electrocardiogram (ECG), which enables early detection of abnormalities. Conventionally, ECG systems are wired, limiting continuous monitoring and patient comfort. Thanks to technology, portable and wireless ECG systems have also been developed, based mainly on efficient radio frequency (RF) technologies, which enable these users to be monitored regularly. However, security and privacy requirements, interference generation, potential harmful effects on patient health, spectrum congestion and energy efficiency are challenges for the massive deployment of RF technologies in healthcare scenarios. Instead of relying on the limitations of RF systems, this thesis focuses on an alternative solution based on optical wireless technologies that enable safe and environmentally-friendly communications. This solution consists of a monitoring system using an infrared link between a transmitter embedded in an ECG sensor placed on the user's body and receivers placed on the ceiling of the environment. In order to study the three monitoring contexts, the corresponding optical channel was simulated using a ray-tracing technique combined with the numerical Monte-Carlo method. Considering the specificities of the monitoring scenario, the population (age and mobility) and the modeled environment (transparent material of premature baby incubators), the static gain characterizing the channel was obtained. This gain was used in a chain developed to simulate ECG transmission in each context. The reliability of the proposed remote monitoring system is thus conditioned by the quality of the transmitted ECG signal. This has been assessed at application level using the Signal Quality Index (SQI) method, which consists in extracting spectral and statistical characteristics from the ECG. In addition, given its usefulness in monitoring the development of premature infants, heart rate variability (HRV) has also been analyzed by computing the temporal parameters that characterize RR intervals in an ECG. The main objective is to assess the impact of time-varying optical transmission performance on the quality of the received ECG signal, in order to design a less intrusive, reliable and cost-effective system for remote ECG signal monitoring. SQIs consist in extracting spectral and statistical characteristics from the ECG. In addition, given its usefulness in monitoring the development of premature infants, heart rate variability (HRV) was also analyzed by computing the temporal parameters that characterize RR intervals. The main objective is to assess the impact of optical transmission performance on ECG quality metrics. For this purpose, a general analysis approach was implemented to jointly study the evolution of (SQIs) and VFC temporal parameters at the application level as a function of classical metrics at the physical level, namely (SNR) and (BER). The results of this research showed the potential of using wireless optics in such medical contexts to provide a reliable and energy-efficient solution. Indeed, in all three cases investigated, ECG signals of sufficient quality for reliable diagnoses were obtained at moderate levels of transmitted optical power, which is important for a portable medical remote monitoring system
Leroy, Sylvie. "Traçabilité informatique des dispositifs médicaux implantables : création du logiciel "VIGIPHARM R version dispositifs médicaux"". Paris 5, 1997. http://www.theses.fr/1997PA05P199.
Testo completoHuot, Laure. "Evaluation clinique des dispositifs médicaux". Phd thesis, Université Claude Bernard - Lyon I, 2012. http://tel.archives-ouvertes.fr/tel-00983482.
Testo completoNeveu, David. "La normalisation des dispositifs médicaux". Bordeaux 2, 1997. http://www.theses.fr/1997BOR2P105.
Testo completoLe, Moual Sylvie. "Assurance qualité des dispositifs médicaux". Paris 5, 1992. http://www.theses.fr/1992PA05P248.
Testo completoAbed, Aïcha. "Nouveaux dispositifs médicaux à base d'hydrogels de polysaccharides". Paris 13, 2012. http://www.theses.fr/2012PA132062.
Testo completoThis work describes the development of new medical devices based on hydrogel of polysaccharides (pullulan and dextran). In recent years, our laboratory was interested in the biological properties of synthetic or natural polysaccharides and their interactions with endogenous growth factors and matrix components. So we had the idea to apply their properties to the design of a hybrid material composed of a polypropylene mesh coated with polysaccharides hydrogel. The first objective of this work is to improve the integration of materials currently used in clinical by using of hybrid prosthesis and understand the properties of these hydrogels in vitro and in vivo. In the second part of this work, based on the hydrogel properties a new system of storage and transport of tissue at room temperature was developed while limiting mechanical shocks and contamination associated with leaking fluids. Taking as a model of rat arteries, we validated this system in vitro and in vivo. Finally, we developed a new system for cryopreservation of cells and tissues. This hydrogel based polysaccharides reduces the quantities of toxic cryoprotectants agents during freezing. This method was validated in vitro and in vivo and in comparison with the reference procedure
Lamarche, Juliette. "Les dispositifs médicaux non réutilisables de circulation extra-corporelle". Paris 5, 1997. http://www.theses.fr/1997PA05P148.
Testo completoMaho, Thomas. "Stérilisation de dispositifs médicaux ensachés par plasmas froids basse pression". Thesis, Orléans, 2016. http://www.theses.fr/2016ORLE2077.
Testo completoStandard sterilization methods such as autoclave, ethylene oxide or irradiation can affect the biocompatibility of medical devices, especially those sensitive to heat or chemicals products. Numerous studies have demonstrated the possibility to use low pressure plasmas as an alternative sterilization process: low process temperature, treatment time competitive to autoclave and without any toxic agent. However, the sterile state preservation is still a problem. In the framework of the ANR PLAS'STER project, this CIFRE thesis focus on a new sterilization process development based on low pressure cold plasmas. The innovation resides in the creation and the confinement of a plasma inside a sterilization bag, thereby ensuring the conservation of the sterile state. The first part was dedicated to the physical characterization of the plasmas discharges confined inside the bag of sterilization. Secondly, the bactericidal efficiency of the process was demonstrated on Gram negative and Gram positive bacteria according to the EN556 standard. Additional tests on E. coli lead to hypothesis on the sterilization mechanisms and opened tracks on the optimization of our process. Finally, the properties analysis of biomaterials demonstrated the absence of macromolecular modifications and validated the potentiality of the process PLAS' STER as the sterilization method alternative
Ethgen, Bonnet Morgane. "Méthodes d'évaluation des traitements non pharmacologiques : l'exemple des dispositifs médicaux implantables". Paris 6, 2012. http://www.theses.fr/2012PA066184.
Testo completoOur first study was to compare the reporting f harm in trials of pharmacologic (PT) and nonpharmacologic treatment (NPT). 193 articles were analysed. After adjustement for medical areas, sample size, funding source, and multicenter trails, data on harm were more often described in PT reports than in NPT reports in reporting dverse events. The lack of reporting harm in trials assessing NPT in rheuatic disease is an important barrier to evaluating the benefit-harm balance of NPT. Our second work evaluated the harm reporting and the quality of internal and external validity in published reports evaluating the stent for percutaneous coronary intervention. 132 articles were analyzed. The volume of interventions per center was described in 2 reports, and in 5 reports for operator expertise. The generation of allocation sequence was adequate in 58. 3%, treatment allocation was concealed in 34. 8%. Several harm related data were not adequately accounted for in articles and the current reprting of results of RCTs testing stents needs to be improved to allow readers to appraise the risk of biais and the applicability of results
Folefack, Ernest. "Recherches sur le droit international des médicaments et des dispositifs médicaux". Bordeaux 4, 1998. http://www.theses.fr/1998BOR40034.
Testo completoThe objective of the author is prouve the existence of international law rules regulating the movement of drugs and medical devices in the international market. These rules are mainly produced by international organisations with competence on health either on the universal basis (see who) or regional basis (eu or the european council). Thesis rules have strong links with technical regulation such as standard. Theses rules have public health purposes since they are aimed at maintaining the quality of drugs and medical devices as regard safety of patients. They are imposed at all stages of the production of drugs from the conception (international and national pharmacopoeia, glp), the stage of manufacturing (gmp) the respect of legal and ethical rules concerning the testing of new drugs on human being (gcp), the harmonisation of new drugs registration procedures, the rational use of drugs and medical devices based on adequates information, restriction of publicity and an overrall worldwide monitoring of the use of drugs and medical devices. But a global international legal coherent system of regulation of drugs and medical devices is yet to be consolidated
Libri sul tema "Télésurveillance des dispositifs médicaux"
normalisation, Association française de. Stérilisation des dispositifs médicaux. Saint-Denis La Plaine: AFNOR, 2004.
Cerca il testo completoWorld Health Organization (WHO). Dons de dispositifs médicaux: Considérations relatives à leur demande et à leur attribution. Switzerland: World Health Organization, 2012.
Cerca il testo completoLaval, Guillemette. Soins palliatifs: Les principales thérapeutiques en soins palliatifs chez l'adulte et la personne âgée : médicaments, dispositifs médicaux, prescriptions de sortie. 3a ed. Montpellier: Sauramps médical, 2006.
Cerca il testo completoStérilisation des dispositifs médicaux. Paris: AFNOR, 1999.
Cerca il testo completoWorld Health Organization (WHO). Package Série Technique de l'OMS Sur les Dispositifs Médicaux. World Health Organization, 2012.
Cerca il testo completoWorld Health Organization (WHO). Liste interinstitutions de dispositifs médicaux prioritaires pour des interventions essentielles: En santé reproductive, maternelle, néonatale et infantile. World Health Organization, 2017.
Cerca il testo completoMABANZA, Tryphon. Incidents Critiques d'une Machine d'anesthÉsie Clinique Hier et AUJOURD'HUI: Une Introduction Aux Normes des Dispositifs Médicaux et des Stratégies Efficaces Pour Son Contrôle d'assurance Qualité Quotidien et Régulier. Independently Published, 2021.
Cerca il testo completoCapitoli di libri sul tema "Télésurveillance des dispositifs médicaux"
Gaillard, C., A. Capelle e X. Armoiry. "Dispositifs médicaux en oncologie". In Pharmacie Clinique Pratique en Oncologie, 82–94. Elsevier, 2020. http://dx.doi.org/10.1016/b978-2-294-76375-5.00010-5.
Testo completoCallanquin, J., C. Camuzeaux e P. Labrude. "Dispositifs Médicaux et Matériovigilance". In Le matériel de maintien à domicile, 15–32. Elsevier, 2008. http://dx.doi.org/10.1016/b978-2-294-08853-7.50002-2.
Testo completoGaillard, Claire, e Daniel Hartmann. "Biocompatibilité des dispositifs médicaux". In Pharmacie clinique et dispositifs médicaux, 51–55. Elsevier, 2023. http://dx.doi.org/10.1016/b978-2-294-77399-0.00008-9.
Testo completoGhislain, Jean-Claude. "Approche réglementaire des dispositifs médicaux". In Pharmacie clinique et dispositifs médicaux, 13–16. Elsevier, 2023. http://dx.doi.org/10.1016/b978-2-294-77399-0.00002-8.
Testo completoCabelguenne, Delphine, Pierre Cassier, El-Mahdi Hafiani, Vincent Létoublon, Marie Selvy e Valérie Sautou. "Dispositifs médicaux et développement durable". In Pharmacie clinique et dispositifs médicaux, 91–96. Elsevier, 2023. http://dx.doi.org/10.1016/b978-2-294-77399-0.00014-4.
Testo completoSalomez-Ihl, Cordélia, Rémy Collomp, Alexandre Moreau-Gaudry e Pierrick Bedouch. "e-santé et dispositifs médicaux". In Pharmacie clinique et dispositifs médicaux, 327–41. Elsevier, 2023. http://dx.doi.org/10.1016/b978-2-294-77399-0.00036-3.
Testo completoGaillard, Claire, Daniel Hartmann e Yves François. "Les dispositifs médicaux en stomathérapie". In Pharmacie clinique et dispositifs médicaux, 233–38. Elsevier, 2023. http://dx.doi.org/10.1016/b978-2-294-77399-0.00026-0.
Testo completoChambrin, Pierre-Yves, e Gilles Aulagner. "Évaluation clinique des dispositifs médicaux". In Pharmacie clinique et dispositifs médicaux, 17–20. Elsevier, 2023. http://dx.doi.org/10.1016/b978-2-294-77399-0.00003-x.
Testo completoGoeury, Dominique, Gilles Aulagner, Olivier Claris e Frédérique Perlier. "Le retraitement des dispositifs médicaux à usage unique". In Pharmacie clinique et dispositifs médicaux, 79–84. Elsevier, 2023. http://dx.doi.org/10.1016/b978-2-294-77399-0.00012-0.
Testo completoCabelguenne, Delphine, Damien Royané, Vincent Piriou e Stéphanie Genay. "Principes de la perfusion médicamenteuse et dispositifs médicaux utilisés en perfusion intraveineuse". In Pharmacie clinique et dispositifs médicaux, 99–111. Elsevier, 2023. http://dx.doi.org/10.1016/b978-2-294-77399-0.00015-6.
Testo completoAtti di convegni sul tema "Télésurveillance des dispositifs médicaux"
Danet, C., V. Duhalde, A. Culetto, K. Barange, L. Buscail, C. Barrué, I. Labadens e P. Cestac. "Comment informer les professionnels de santé sur les Dispositifs Médicaux? Création en endoscopie digestive d'un outil pilote informatique connecté au livret des Dispositifs Médicaux de l'hôpital". In Journées Francophones d'Hépato-Gastroentérologie et d'Oncologie Digestive (JFHOD). Georg Thieme Verlag KG, 2019. http://dx.doi.org/10.1055/s-0039-1680970.
Testo completo